Solvotrin Theraputics is an Irish headquartered healthcare company committed to developing cutting edge science to address unmet clinical needs.
ActiveIron® is Kind & Strong. Kind enough to take on an empty stomach, with Strong absorption when you need it. Visit www.myactiveiron.com for more information.
ActiveIron®
Solvotrin Therapeutics is dedicated to sound scientific research focused on primarily developing and marketing patented novel products.
Solvotrin Therapeutics is a privately held Irish healthcare and medicine development company. Our vision is to utilize innovative science to create products that deliver on significant unmet clinical needs. Our development is focused on optimizing established therapies to bring a significant improvement in clinical outcomes and ultimately improve the quality of life for patients across the world. Solvotrin Therapeutics launched its first product Active Iron in 2016. This iron product was developed together with scientists at Trinity College Dublin.
Solvotrin News
Solvotrin Therapeutics: Improving the tolerance and effectiveness of iron and aspirin
Enterprise Ireland has recently published an interview with Solvotrin CEO…
Solvotrin take final step to bring Active Iron to China
Solvotrin Therapeutics and a division of the Shanghai Fosun Pharmaceutical…
Solvotrin Therapeutics and Roha APD new partnership poised to invigorate German oral iron market
Irish healthcare and medicines development company Solvotrin Therapeutics has partnered…
Solvotrin Therapeutics and Amophar to bring Active Iron to 3 new European markets
Irish Healthcare and medicines development company Solvotrin Therapeutics has partnered…
Trinity Pharmacy School Prize Giving and Industry Networking Event December 2018
Trinity College Dublin’s School of Pharmacy welcomed colleagues from the…
Solvotrin Therapeutics sets sights on China
Solvotrin Therapeutics and Shanghai Fosun Pharmaceutical have agreed to enter…
ActiveIron Wins ‘Best Maternity Supplement’ 2018
ActiveIron has been announced as the winner in the Best…
TCD SPIN OUT – SOLVOTRIN THERAPEUTICS SET TO COMMERCIALISE PATENTED ‘ACTIVEIRON’ TECHNOLOGY
Addresses Major Supplementation Barrier – Iron Intolerance Demonstrated Superior Bioavailability…
Solvotrin Therapeutics wins InterTrade Ireland Award
Cork Companies recognised as shining lights of the Irish SME…
Solvotrin Therapeutics wins InterTradeIreland “Project Exemplar” Award
Pictured at the presentation of the InterTradeIreland “Project Exemplar” award…
Irish pharmaceutical firm works on cancer-prevention drug (Silicone Republic)
Irish pharmaceutical company Solvotrin Therapeutics is developing a range of…
Solvotrin CEO Addresses “IRELAND DAY” at the New York Stock Exchange
Pictured at the New York stock exchange on Monday 14th…
Minister for Enterprise, Trade and Innovation, Batt O’Keeffe visits Solvotrin Therapeutics office in Cork
From left to right: Batt O’Keeffe (Minister for Enterprise, Trade…
Heart of the matter: Cardiovascular drug the big idea in Irish innovation
Life-science & Food Commercialisation Award winner Pat O'Flynn (left), of…
Merck to market: Life science firms pitch to Pharma giant (Irish Times)
IRELAND’S INDIGENOUS life sciences industry was showcased at an event…
